original ) (raw )Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified `coasting' strategy based on ultrasound for identification of high-risk patients
sajid hussain
Human Reproduction, 2001
View PDFchevron_right
Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles
Evangelos Papanikolaou , Michel Camus
Fertility and Sterility, 2006
View PDFchevron_right
A new treatment to avoid severe ovarian hyperstimulation utilizing insights from in vitro maturation therapy
Bruce Rose
Journal of Assisted Reproduction and Genetics, 2013
View PDFchevron_right
Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization
Martha Aguirre
Fertility and Sterility, 2005
View PDFchevron_right
What is the best predictor of severe ovarian hyperstimulation syndrome in IVF? A cohort study
Yvon Englert
Journal of Assisted Reproduction and Genetics, 2017
View PDFchevron_right
Minimal monitoring of ovarian hyperstimulation: a useful simplification of the clinical phase of in vitro fertilization treatment
Arne van Heusden
Fertility and Sterility, 1995
View PDFchevron_right
Prevention of severe ovarian hyperstimulation by coasting
Marc Dhont
Fertility and Sterility, 1998
View PDFchevron_right
Low serum estradiol concentrations after five days of controlled ovarian hyperstimulation for in vitro fertilization are associated with poor outcome
Peter Braude
Fertility and Sterility, 2000
View PDFchevron_right
Comparison of coasting and intravenous albumin in the prevention of ovarian hyperstimulation syndrome
Hong-Nerng Ho
Fertility and Sterility, 2003
View PDFchevron_right
Prediction of severe ovarian hyperstimulation syndrome in women undergoing in vitro fertilization using estradiol levels, collected ova, and number of follicles
Elba Mejia
Journal of International Medical Research
View PDFchevron_right
Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups
jose luis Hurtado Balmaceda
Human Reproduction, 1991
View PDFchevron_right
Combined approach as an effective method in the prevention of severe ovarian hyperstimulation syndrome
ahmet isik
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2001
View PDFchevron_right
Repeated in vitro fertilization cycle attempts in patients undergoing controlled ovarian hyperstimulation with use of gonadotropin-releasing hormone antagonists
Raoul Orvieto
Fertility and Sterility, 2009
View PDFchevron_right
Reduction of human menopausal gonadotropin dose before coasting prevents severe ovarian hyperstimulation syndrome with minimal cycle cancellation
Mohamed Aboulghar
Journal of assisted reproduction and genetics, 2000
View PDFchevron_right
Low-dose HCG is useful in preventing OHSS in high-risk women without adversely affecting the outcome of IVF cycles
Rex J Scaramuzzi
Reproductive BioMedicine Online, 2007
View PDFchevron_right
In Vitro Maturation of Oocytes in Women at Risk of Ovarian Hyperstimulation Syndrome-A Prospective Multicenter Cohort Study
international journal of fertility and sterility Int J Fertil Steril
Volume 13, Number 1, Apr-Jun 2019 Pages: 38-44, 2019
View PDFchevron_right
Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting
John Nulsen
Fertility and Sterility, 2010
View PDFchevron_right
An update on the prevention of ovarian hyperstimulation syndrome
Julia Kopeika
Women's Health, 2016
View PDFchevron_right
Abou-Setta, “Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome
Mohamed Aboulghar
2005
View PDFchevron_right
Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr
Murat Arslan
Fertility and Sterility, 2005
View PDFchevron_right
Sliding scale HCG trigger yields equivalent pregnancy outcomes and reduces ovarian hyperstimulation syndrome: Analysis of 10,427 IVF-ICSI cycles
Vinay Gunnala
PloS one, 2017
View PDFchevron_right
Critical ovarian hyperstimulation syndrome in a coasted in-vitro fertilization patient
Peter McGovern
Human Reproduction, 1998
View PDFchevron_right
Poor responders to ovarian hyperstimulation may benefit from an attempt at natural-cycle oocyte retrieval
Andrea Vidali
Journal of Assisted Reproduction and Genetics, 1997
View PDFchevron_right
Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting: a new strategy to avoid ovarian hyperstimulation syndrome
Leyre Herrero
Fertility and Sterility, 2011
View PDFchevron_right
Day 4 Estradiol Levels Predict Pregnancy Success in Women Undergoing Controlled Ovarian Hyperstimulation for IVF
John Phelps , Adam Levine
Fertility and Sterility, 2000
View PDFchevron_right
Ovarian hyperstimulation syndrome and assisted reproductive technologies: why some and not others?
Neil McClure
Human Reproduction, 2002
View PDFchevron_right
The value of delaying hCG administration to enable maturation of medium-sized follicles in patients undergoing superovulation for IVF/ICSI
Awoniyi Awonuga
Journal of Assisted Reproduction and Genetics, 2017
View PDFchevron_right
Is the modified natural in vitro fertilization cycle justified in patients with “genuine” poor response to controlled ovarian hyperstimulation?
Gil M Yerushalmi
Fertility and Sterility, 2014
View PDFchevron_right
Risk factors for ovarian hyperstimulation syndrome in Thai patients using gonadotropins for in vitro fertilization
K. Pruksananonda
American Journal of Health-System Pharmacy, 2008
View PDFchevron_right